首页> 美国卫生研究院文献>other >Core decompression lesion clearance and bone graft in combination with Tongluo Shenggu decoction for the treatment of osteonecrosis of the femoral head
【2h】

Core decompression lesion clearance and bone graft in combination with Tongluo Shenggu decoction for the treatment of osteonecrosis of the femoral head

机译:核心减压病灶清除和植骨联合通络生骨汤治疗股骨头坏死

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to evaluate the clinical effect of core decompression (CD), lesion clearance, and bone graft in combination with Tongluo Shenggu decoction for the treatment of osteonecrosis of the femoral head (ONFH).A total of 75 patients (92 hips), with ONFH at Association Research Circulation Osseous (ARCO) stages II to IIIA, were studied and divided into treatment group and control group. In control group, patients were treated with the CD in combination with autologous or artificial ceramic bone graft. In treatment group, patients were treated with the above method combined with Tongluo Shenggu decoction. Patients were followed-up at 1 month, 6 months, and 24 months after surgery. The visual analogue scale (VAS) scores, Harris Hip Score (HSS), and total effective rates were measured and recorded.The total effective rate of the treatment group was significantly higher than that of the control group (97.2% vs. 89.9%, P < .05). Compared with preoperative, the VAS and HSS scores were both improved at final follow-up, and there was significant difference between 2 groups (P < .01).The combination of CD, lesion clearance, and the bone graft with Tongluo Shenggu decoction is safe and effective for the treatment of ONFH, owing to which it can provide higher postoperative functional outcomes, reduce pain, and achieve smaller osteonecrosis area and better bone changes.
机译:这项研究的目的是评估核心减压(CD),病灶清除和骨移植联合通络生骨汤治疗股骨头坏死(ONFH)的临床效果。共75例患者(92髋关节)在ONFH的II至IIIA期进行了研究,分为治疗组和对照组。对照组采用CD结合自体或人工陶瓷植骨治疗。治疗组采用上述方法联合通络生骨汤治疗。术后1个月,6个月和24个月对患者进行随访。测量并记录视觉模拟量表(VAS)评分,Harris Hip评分(HSS)和总有效率。治疗组的总有效率显着高于对照组(97.2%vs. 89.9%, P <.05)。与术前相比,VAS和HSS评分在末次随访时均有所改善,两组之间差异有统计学意义(P <.01)。CD,病变清除率,通络生骨汤联合骨移植治疗效果良好。安全有效地治疗ONFH,因为它可以提供更高的术后功能结局,减轻疼痛并实现更小的骨坏死面积和更好的骨骼变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号